These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 19212641)

  • 1. Combined chemo- and immunotherapy of tumors induced in mice by bcr-abl-transformed cells.
    Sobotkova E; Duskova M; Tachezy R; Petrackova M; Vonka V
    Oncol Rep; 2009 Mar; 21(3):793-9. PubMed ID: 19212641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony-stimulating factor: I. Derivation, genetic stability, oncogenicity and immunogenicity.
    Petráčková M; Tachezy R; Vonka V
    Int J Oncol; 2012 May; 40(5):1668-76. PubMed ID: 22327125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J; Hu P; Khawli LA; Epstein AL
    Cancer Res; 2003 Dec; 63(23):8384-92. PubMed ID: 14679000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of reovirus therapy combined with cyclophosphamide and gene-modified cell vaccines on tumors induced in mice by HPV16-transformed cells.
    Sobotkova E; Duskova M; Eckschlager T; Vonka V
    Int J Oncol; 2008 Aug; 33(2):421-6. PubMed ID: 18636165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF.
    Petráčková M; Staněk L; Mandys V; Dundr P; Vonka V
    Int J Oncol; 2012 Jun; 40(6):1915-22. PubMed ID: 22446515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy and immunotherapy of tumours induced by gene-modified HPV16-transformed cells.
    Sobotková E; Dusková M; Smahel M; Holán V; Janousková O; Vonka V
    Oncol Rep; 2004 Oct; 12(4):877-83. PubMed ID: 15375516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imatinib mesylate effectively combines with chaperone-rich cell lysate-loaded dendritic cells to treat bcr-abl+ murine leukemia.
    Zeng Y; Graner MW; Feng H; Li G; Katsanis E
    Int J Cancer; 2004 Jun; 110(2):251-9. PubMed ID: 15069690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with leukemia cells expressing cell-surface-associated GM-CSF blocks leukemia induction in immunocompetent mice.
    Ling X; Wang Y; Dietrich MF; Andreeff M; Arlinghaus RB
    Oncogene; 2006 Jul; 25(32):4483-90. PubMed ID: 16547503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccination against bcr-abl-positive cells in mice.
    Lucansky V; Sobotkova E; Tachezy R; Duskova M; Vonka V
    Int J Oncol; 2009 Oct; 35(4):941-51. PubMed ID: 19724931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside.
    Lin JM; Li B; Rimmer E; VanRoey M; Jooss K
    Exp Hematol; 2008 Mar; 36(3):319-28. PubMed ID: 18279719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristic of two mouse bcr-abl-transformed cell lines: I. General properties of the cells.
    Sobotkova E; Ludvíková V; Petrácková M; Dusková M; Smetana K; Jelínek F; Marinov I; Vonka V
    Folia Biol (Praha); 2005; 51(1):12-8. PubMed ID: 15783087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unexpected properties of endostatin-producing mouse BCR-ABL-transformed cells.
    Krmenčíková M; Staněk L; Petráčková M; Dundr P; Vonka V
    Int J Oncol; 2012 Feb; 40(2):487-93. PubMed ID: 21956144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recombinant eukaryotic expression plasmid of bcr-abl gene fragment induces specific immune response in mice].
    Jiang YW; Qian L; Gong WJ; Liu W; Jiang GH; Ji MC
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):111-5. PubMed ID: 16732966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.
    Zeng Y; Graner MW; Thompson S; Marron M; Katsanis E
    Blood; 2005 Mar; 105(5):2016-22. PubMed ID: 15374884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immune protective mechanisms of gene vaccines with co-expressing bcr-abl fusion gene fragment and mouse IL-7 gene].
    Ji MC; Jiang YW; Liu W; Guan J; Qian L; Gong WJ
    Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):93-5. PubMed ID: 17645839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
    Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergy between dendritic cells and GM-CSF-secreting tumor cells for the treatment of a murine renal cell carcinoma.
    Driessens G; Hoffmann P; Pouwels M; Zlotta A; Schulman C; Velu T; Bruyns CA
    J Immunother; 2009; 32(2):140-4. PubMed ID: 19238012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.
    Kedar E; Chriqui-Zeira E; Kyriazis AP
    J Biol Response Mod; 1984 Oct; 3(5):517-26. PubMed ID: 6334139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.